Phase 2 Alopecia Areata Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a man or woman who has been diagnosed with breast cancer that has spread to other parts of the body (metastatic), and you are still able to carry out basic daily activities (confirm with trial site regarding activity level assessment)
- You are 18 years old or older
- You still have hair at the time of joining the trial (you have not already lost your hair)
- You are planned to receive at least 4 cycles of one of these specific chemotherapy treatments: Sacituzumab govitecan, Trastuzumab deruxtecan, or Eribulin, at the full standard doses
- If you choose to be in the scalp cooling group, you must start using the Paxman Scalp Cooling System from your very first chemotherapy dose
Who may not be able to join:
- You have a known blood cancer, such as leukemia or lymphoma
- Cancer has spread to your scalp
- You are already experiencing hair loss before the trial begins
- You have a condition called cold agglutinin disease or cold urticaria (conditions where your body reacts badly to cold temperatures)
- You are scheduled to receive very high-dose chemotherapy that wipes out your bone marrow
- You have a personal medical diagnosis of migraines, cluster headaches, or tension headaches, or have been prescribed medication for these — though if this was a past problem that has fully resolved, the lead doctor may still consider you (confirm with trial site)
- You have lichen planus or lupus
- You are currently receiving any other cancer treatments alongside the ones listed above
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Elahe Salehi, DNP, ANP-BC, Dana-Farber Cancer Institute
Phone: 617-632-3800
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Hair Loss Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.